最近在基于生物标志物诊断Helicobacter pylori的进展,胃癌引起的细菌
Kirti Saxena1, Akanksha Deshwal1, Ramesh Namdeo Pudake1
1Amity Institute of Nanotechnology (AINT), Amity University Uttar Pradesh (AUUP), Sector 125, Noida, 201313, India.
本综述强调了用于诊断Helicobacter pylori感染和早期胃癌的新生物标志物. 这些包括尿酶,DNA,miRNA,体和细菌用于先进的生物传感平台.
科学领域:
- 微生物学与传染病的研究
- 生物标志物发现发现
- 医学诊断 医学诊断 医学诊断
背景情况:
- 疾病的进展涉及病原体,宿主因素和环境之间的复杂相互作用.
- 了解细菌毒素对于开发疫苗等诊断和疗法至关重要.
- 杆菌是与胃疾病有关的重要病原体.
研究的目的:
- 审查最近用于诊断Helicobacter pylori感染的生物标志物.
- 探索各种生物标志物在检测H. pylori和早期胃癌方面的实用性.
- 讨论这些生物标志物在开发敏感生物传感平台中的应用.
主要方法:
- 关于H. pylori生物标志物的最近研究的文献综述.
- 对不同类型的生物标记物的分析:尿素酶,DNA,miRNA,体和细菌菌体.
- 在生物传感器开发中检查生物标记物的利用.
主要成果:
- 鉴定出尿酶,DNA,miRNA,体和细菌作为检测H. pylori的关键生物标志物.
- 证明了这些生物标志物在早期胃癌诊断中的潜力.
- 突出了生物传感平台的进步,利用这些目标获得高特异性和灵敏度.
结论:
- 新型生物标志物为准确的H. pylori诊断和胃癌查提供了有希望的途径.
- 将这些生物标志物集成到生物传感平台中,提高了诊断能力.
- 对这些生物标志物的进一步研究可以导致改善治疗策略和疫苗.
更多相关视频
05:23Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
04:56Detection of Helicobacter pylori Infection and Antibiotic Resistance via Stool Quantitative Polymerase Chain Reaction Analysis
Published on: May 16, 2025
相关概念视频
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Serum Laboratory Studies, Stool Test, Breath Test
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
